US FTC sues to block Amgen’s $27.8 billion deal for Horizon Therapeutics
By Diane Bartz WASHINGTON (Reuters) – The U.S. Federal Trade Commission said on Tuesday it would sue to stop Amgen Inc’s $27.8 billion acquisition of Horizon Therapeutics Plc in a rare move to block a large pharmaceutical deal. In its complaint, the FTC said Amgen would be able to leverage the powerful position it has with insurance companies and pharmacy benefit managers who want access to its blockbuster drugs to […]